American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines
Maron BJ et al. (2003) American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 42: 1687-1713
Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction
Maron MS et al. (2006) Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation 114: 2232-2239
Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy
Maron MS et al. (2003) Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 348: 295-303
The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to severity of symptoms
Autore C et al. (2005) The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to severity of symptoms. J Am Coll Cardiol 45: 1076-1080
Long-term effects of surgical septal myeatomy on survival in patients with obstructive hypertrophic cardiomyopathy
Ommen SR et al. (2005) Long-term effects of surgical septal myeatomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardio 46: 470-476
Time course of pressure gradient response after first alcohol, septal ablation for.obstructive hypertrophic cardiomyopathy
Yoerger DM et al. (2006) Time course of pressure gradient response after first alcohol, septal ablation for.obstructive hypertrophic cardiomyopathy. Am J Cardiol 97: 1511-1514
Alcohol septal ablation for hypprtrophic obstructive cardiomyopathy: A systematic review of published studies
Alam M et at. (2006) Alcohol septal ablation for hypprtrophic obstructive cardiomyopathy: A systematic review of published studies. J Interv Cardiol 19: 319-327
latrogenic deaths following.treatment for hypertrophic obstructive cardiomyopathy: Case reports and an approach to the autopsy and death certification
Batalis NI et al. (2005) latrogenic deaths following.treatment for hypertrophic obstructive cardiomyopathy: Case reports and an approach to the autopsy and death certification. Am J Forensic Med Pathol 26: 343-348
Targeting percutaneous transluminal septal ablation for hypertrophic obstructive cardiomyopathy by intraprocedural echocardiographic monitoring
Faber L et al. (2000) Targeting percutaneous transluminal septal ablation for hypertrophic obstructive cardiomyopathy by intraprocedural echocardiographic monitoring. J Am Soc Echocardiogr 13: 1074-1079
Effects of varying ethanol dosing in percutaneous septal ablation for obstructive hypertrophic cardiomyopathy on early hemodynamic changes
Vaselka J et al. (2005) Effects of varying ethanol dosing in percutaneous septal ablation for obstructive hypertrophic cardiomyopathy on early hemodynamic changes. Am J Cardiol 95: 675-678
Comparison of surgical septal myeatomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy
Valeti US et al. (2007) Comparison of surgical septal myeatomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 49: 350-357
Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Evaluation by contrast-enhanced magnetic resonance imaging
Van Dockum WG et al. (2004) Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Evaluation by contrast-enhanced magnetic resonance imaging. J Am, Coll Cardiol 43: 27-34